Loading
No insider purchase over the last 90 days. The latest, by Thigpen Mary E, was filed 26 Jul 2024.
Insider Decl.
1,515
Thresholds
n/a
Buy Volume
€2M
13 ops. · all time
Sell Volume
€516M
542 ops. · all time
Who traded when
BuySaleSvoboda Frank M20 sales
James Matthew Darden14 sales
Michael Clay Majors11 sales
Thomas Peter Kalmbach11 sales
Zorn Rebecca E10 sales
Henrie Michael Shane9 sales
+6 other insiders
Since the insiders bought
- +45.7%Entry US$92.07 · Close at T+365 US$134.16
- +46.9%Entry US$82.37 · Close at T+365 US$120.97
- +48.2%Entry US$80.55 · Close at T+365 US$119.41
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Globe Life Inc. Buy (bullish), based on 11 analysts. Average price target: US$193.18.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 2,234 of 26,246 companies
75.4
score / 100
Value74
Quality76
FCF yld9.6%
Earn yld8.9%
EV/EBITDA9.3x
ROE21%
Gross mgn·
Net mgn19%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$169.62
Analyst consensus
11 analystsBuy
US$166.00Target US$193.18(+14%)US$225.00
Income statement
RevenueUS$6B
EBITDAUS$1.7B28% margin
Net incomeUS$1.2B19.6% margin
Valuation
PER (trailing)11.3x
PER (forward)10.3x
P/Book2.1x
Beta0.44
Balance sheet & cash
Market capUS$13B
Total debtUS$2.6B
Free Cash FlowUS$1.3B
Debt / Equity56%
Profitability & ownership
ROE20.9%
ROA3.4%
% insiders0.7%
% institutions87.4%
Last declaration on 23 September 2026
Declarations1,515 total
10,000 shares@ US$103.230.0079% mcap27.4% of flowCommon StockSEC:0000320335-26-000222:0
3,344 shares@ US$169.53110.0043% mcap15.1% of flowCommon StockSEC:0000320335-26-000222:1
6,656 shares@ US$170.34090.0087% mcap30.1% of flowCommon StockSEC:0000320335-26-000222:2
10,000 shares@ US$172.160.013% mcap100.0% of flowCommonSEC144:0001654954-26-008516
16,500 shares@ US$177.910.021% mcap42.5% of flowCommonSEC144:0001654954-26-007582
23,000 shares@ US$103.230.018% mcap10.5% of flowCommon StockSEC:0000320335-26-000220:0
11,454 shares@ US$182.76680.016% mcap9.3% of flowCommon StockSEC:0000320335-26-000220:1
10,529 shares@ US$183.82990.015% mcap8.6% of flowCommon StockSEC:0000320335-26-000220:2
1,017 shares@ US$184.75130.0014% mcap0.8% of flowCommon StockSEC:0000320335-26-000220:3
23,000 shares@ US$183.900.032% mcap100.0% of flowCommonSEC144:0001654954-26-007301
400 shares@ US$183.35750.0006% mcap0.3% of flowCommon StockSEC:0000320335-26-000214:2
50,000 shares@ US$98.320.037% mcap20.0% of flowCommon StockSEC:0000320335-26-000214:0
49,600 shares@ US$182.42530.069% mcap36.8% of flowCommon StockSEC:0000320335-26-000214:1
33,500 shares@ US$178.56130.046% mcap21.6% of flowCommon StockSEC:0000320335-26-000208:1
37,000 shares@ US$103.230.029% mcap13.8% of flowCommon StockSEC:0000320335-26-000208:0
3,500 shares@ US$179.3490.0048% mcap2.3% of flowCommon StockSEC:0000320335-26-000208:2
11,000 shares@ US$120.490.010% mcap6.5% of flowCommon StockSEC:0000320335-26-000210:1
10,720 shares@ US$179.29720.015% mcap9.5% of flowCommon StockSEC:0000320335-26-000210:2
4,840 shares@ US$180.0780.0067% mcap4.3% of flowCommon StockSEC:0000320335-26-000210:3
2,650 shares@ US$181.22840.0037% mcap2.4% of flowCommon StockSEC:0000320335-26-000210:4
2,790 shares@ US$181.81490.0039% mcap2.5% of flowCommon StockSEC:0000320335-26-000210:5
10,000 shares@ US$103.230.0079% mcap5.1% of flowCommon StockSEC:0000320335-26-000210:0
50,000 shares@ US$179.170.069% mcap100.0% of flowCommonSEC144:0001654954-26-006973
14,100 shares@ US$120.490.013% mcap8.4% of flowCommon StockSEC:0000320335-26-000206:0
11,550 shares@ US$128.400.011% mcap7.4% of flowCommon StockSEC:0000320335-26-000206:1
25 of 1515 declarations
About Globe Life Inc.
Globe Life Inc. has 542 sales worth EUR 516.0 million (median EUR 809,568) and 13 purchases worth EUR 1.8 million (median EUR 146,675), purchases being 2% of open-market trades. The largest sale is Bill Leavell's: EUR 14,106,847 on August 29, 2018. James Matthew Darden, Co-Chairman & CEO, sold EUR 7,855,729 on July 31, 2026, and Robert Brian Mitchell (EVP, General Counsel and CRO) EUR 5,887,134 on October 24, 2025.
Purchases group in spring 2024: from April 24, 2024 to May 21, 2024, 7 filers bought EUR 1,155,084. Frank M. Svoboda (Co-Chairman & CEO) bought EUR 198,663 on May 20, 2024 and EUR 189,480 on May 21, 2024; Mary E. Thigpen (Director) EUR 249,371 on July 26, 2024.
Read moreShow less
Gary L. Coleman (Co-Chairman) signs 155 filings, Larry M. Hutchison 149 and Svoboda 142. 1,515 filings from January 5, 2016 to September 23, 2026, with 427 grants and 426 option exercises. The US finance company is worth USD 13.04 billion, with 60 filers. Last twelve months: 162 filings, 57 sales, no purchase. For the 13 purchases with a result, the 90-day median is 16.1%, with 100% of results positive (recorded past, not a forecast).
